Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Jeito extends global reach in oversubscribed $625M venture fund

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Nov 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Breakthrough science and the future of venture capital

Mar 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

These are the biggest trends in clean tech in 2021

Mar 15
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovation at the intersection of design and technology

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

Dec 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

390 Startup Failure Post-Mortems

Sep 23
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Unicorn Report: Visualizing The Increasingly Crowded Billion-Dollar Company Club

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding